Keywords: match, trial, enrolment, patients, completed, patient, looking
MATCH trial enrolment with 7,600+ patients completed
Article | 10 June 2002
Patient enrolment in a trial looking at the management ofatherothrombosis with Sanofi-Synthelabo/Bristol-Myers Squibbs' Plavix (clopidogrel) in high-risk patients with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
